ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Vizient Announces Agreement with Sri Trang Gloves to Improve Supply Assurance for Nitrile Gloves

Vizient, Inc. today announced an agreement with Thailand-based Sri Trang Gloves for chemo-rated nitrile exam gloves as part of the Vizient Novaplus® Enhanced Supply program. Sri Trang is one of the world’s leading glove manufacturers and the agreement will bring additional supply assurance for this essential component of personal protective equipment required to safely deliver patient care.

Under the Novaplus Enhanced Supply program, suppliers are required to maintain certain levels of onshore inventory to mitigate supply disruptions and demand surges. The program also increases production transparency and greater demand predictability to drive production and supply resiliency.

As part of the agreement with Sri Trang, Vizient members will be able to commit to a monthly purchasing volume for nitrile gloves at any level and then have a matching 90-day, onshore supply maintained by Sri Trang specifically for that provider organization.

“As a result of the pandemic, Vizient members are looking for new ways to engage with manufacturers and distributors for supply assurance,” said Brent Gee, vice president of contract and program services for Vizient. “This agreement with Sri Trang will further ensure supply of nitrile gloves, which are essential for care delivery, in the event of demand spikes for this product.”

Established in 1987, Sri Trang’s operations span all sectors of the natural rubber industry, from rubber plantations and rubber processing to glove production. Currently, Sri Trang has 10 glove manufacturing facilities on 3 campuses in Thailand which produce 35 billion disposable glove pieces annually with exports to 160+ countries globally.

Sri Trang recently announced their intent to establish production in the U.S. The proposed 100-plus acre campus will serve as a North American hub for Sri Trang comprising a nitrile glove manufacturing facility, distribution center and warehouse, and administrative complex. Potential U.S. production is estimated to reach 2.5 billion nitrile gloves annually after the first full year of production. The facility will support Sri Trang’s existing operation in Tampa, Florida – Sri Trang USA, Inc. – and augment their east coast distribution centers.

About Vizient Novaplus

Novaplus Enhanced Supply Program, a Vizient sourcing program, contracts suppliers to provide additional inventory of essential products to mitigate supply disruptions and demand surge. Contract terms provide greater predictability and sustainability to drive continued production and supply resiliency. Production transparency requirements increase visibility to anticipate and further mitigate potential supply disruptions. By purchasing through Novaplus Enhanced Supply, health care facilities also receive expanded value and benefits built on the foundation of the industry’s longest-run private label program.

.@Vizientinc announces agreement with Thailand-based Sri Trang Gloves for chemo-rated nitrile gloves as part of the Vizient Novaplus® Enhanced Supply program.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.